JP Morgan Chase’s Medidata Solutions, Inc. MDSO Stock Holding History

JP Morgan Chase’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,000	Closed	-$570K	–	5750
2017 Q4	$570K	Buy	+9,000	New	+$641K	﹤0.01%	4013
2015 Q1	–	Sell	-23,000	Closed	-$1.1M	–	4372
2014 Q4	$1.1M	Sell	23,000 -977,000	-98%	-$42.3M	﹤0.01%	3293
2014 Q3	$44.3M	Buy	+1,000,000	New	+$44.3M	0.01%	957

Other funds holding MDSO

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

JP Morgan Chase's MDSO Position: Q4 2019 in Review

JP Morgan Chase sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 846,982 shares — an estimated $77.5M sold.

JP Morgan Chase first reported a position in MDSO in Q2 2013 and held it in 23 quarters. The position peaked at $120M in Q2 2017. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

JP Morgan Chase reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
JP Morgan Chase sold 846,982 Medidata Solutions, Inc. shares in Q4 2019, an estimated $77.5M.
JP Morgan Chase first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 23 quarters.
JP Morgan Chase's Medidata Solutions, Inc. position peaked at $120M in Q2 2017.
1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.